Equity Tips

header ads

INDIAN EQUITY MARKET WRAP UP- 2 Jan 2017

Equity Tips

INDIAN BENCHMARKS: SENSEX NIFTY ENDS FLAT

Benchmark indices remained flat after recovery from day's low.

The Sensex was down 19.62 points at 26606.84 and the Nifty declined 1 point to 8184.80. About 1816 shares advanced against 804 declining shares on the BSE.
Natco Pharma has launched a generic Hepatitis C treatment drug in Nepal under the brand name 'Velpanat.' The product is the first generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination sold by Gilead Sciences Inc under brand name Epclusa.

Farm equipment maker Escorts today reported 15.8 percent increase in tractor sales at 3,187 units in December 2016.

HEADLINES OF THE DAY
Bajaj Auto reports weak sales in December.
Lupin gets final nod for generic drug.
Ashok Leyland December sales decline 12% YoY.

The crucial resistance for Nifty spot is now seen at 8230 and above this 8275 Support for the immediate term is now placed at 8120 and next support will be 8050.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Visit Here- http://www.capitalstars.com/ 

Post a Comment

0 Comments